ArticleCancers2024

T-Cell Subtypes and Immune Signatures in Cutaneous Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy.

Magdalena Absmaier-Kijak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.